文献速递浆细胞疾病

己糖激酶-2低表达与多发性骨髓瘤FDG-正电子发射断层扫描假阴性相关

Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma.
PubMed 文献 · Blood · 2017-04-21

研究纳入227例新诊断多发性骨髓瘤患者,同步行FDG-PET与DWIBS评估,发现PET假阴性发生率为11%,且假阴性病例中己糖激酶-2基因表达显著降低(倍数变化5.3,P < .001),为FDG-PET假阴性提供了机制解释。

要点

  • 新诊断多发性骨髓瘤患者中FDG-PET假阴性发生率为11%。
  • 肿瘤负荷参数及浆细胞增殖率均与PET假阴性无关。
  • 己糖激酶-2基因在PET假阴性病例中表达显著降低(倍数变化5.3,P < .001)。

核心结论

  • 研究显示部分多发性骨髓瘤患者FDG-PET呈假阴性,且己糖激酶-2表达与该假阴性强相关,此发现可能对其他血液系统肿瘤的临床影像有意义。

研究设计与样本

  • 研究纳入227例新诊断多发性骨髓瘤患者,同步进行FDG-PET与DWIBS评估,并分析肿瘤内在特征与PET假阴性的关联。

主要发现

  • PET假阴性发生率为11%。
  • 肿瘤负荷相关参数(如骨髓浆细胞浸润程度)及浆细胞增殖率均与PET假阴性亚组无关。
  • 己糖激酶-2基因在PET假阴性病例中表达显著降低(倍数变化5.3,P < .001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

18F-Fluorodeoxyglucose (FDG)-positron emission tomography (PET) and diffusion-weighted magnetic resonance imaging with background signal suppression (DWIBS) are 2 powerful functional imaging modalities in the evaluation of malignant plasma cell (PC) disease multiple myeloma (MM). Preliminary observations have suggested that MM patients with extensive disease according to DWIBS may be reported as being disease-free on FDG-PET ("PET false-negative"). The aim of this study was to describe the proportion of PET false-negativity in a representative set of 227 newly diagnosed MM patients with simultaneous assessment of FDG-PET and DWIBS, and to identify tumor-intrinsic features associated with this pattern. We found the incidence of PET false-negativity to be 11%. Neither tumor load-associated parameters, such as degree of bone marrow PC infiltration, nor the PC proliferation rate were associated with this subset. However, the gene coding for hexokinase-2, which catalyzes the first step of glycolysis, was significantly lower expressed in PET false-negative cases (5.3-fold change, P < .001) which provides a mechanistic explanation for this feature. In conclusion, we demonstrate a relevant number of patients with FDG-PET false-negative MM and a strong association between hexokinase-2 expression and this negativity: a finding which may also be relevant for clinical imaging of other hematological cancers.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Rasche L, Angtuaco E, McDonald JE, et al. Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma. Blood. 2017. PMID: 28432222. doi:10.1182/blood-2017-03-774422

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。